64 postdoc-parallel-computing positions at UNIVERSITY OF SOUTHAMPTON in United Kingdom
Sort by
Refine Your Search
-
generation diagnostics, clean energy and sustainability, marine, photonics and electronics and computer science. You will: work closely with Innovate UK senior leadership to align planned activity with
-
We are seeking a highly motivated post-doctoral researcher of high calibre to join our research program in the area of integrated silicon photonics. The position is funded by the EPSRC (Engineering
-
Southampton Education School is a flourishing centre of research and teaching excellence. It has a well-established programme of Initial Teacher Education in both primary and secondary PGCE, rated
-
The University of Southampton are seeking to appoint a fixed term research fellow to facilitate and deliver a programme of research on a Faraday Institution funded project: SL2FBat - Sustainable Low
-
resources of a new element of the curriculum and will inform the revalidation project team about the development and use of ionof similar/further roles going forwards. On the BM5 programme, students study at
-
and innovation (R&I) ecosystem. This is a unique opportunity to establish or expand your research programme in the UK, collaborate with world-class researchers, and contribute to national and global
-
team, customer service skills across any industry could well be an advantage. The department uses multiple computer systems to deliver its services therefore experience using multiple systems is
-
Technician in ECS Teaching Electronics and Electrical Engineering Laboratories Electronics and Computer Science at the University of Southampton is the UK’s top School integrating Computer
-
of Southampton is hosting and other similar events. You will also engage with staff at the School of Electronics and Computer Science (ECS) from a range of ECS groups and ECS centres, who themselves have exciting
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in